Evidence map›Paper›PMID 30057875›Full record

ReviewCardiovascular diagnosis and therapy2018

Chronic thromboembolic pulmonary hypertension: emerging endovascular therapy.

Keshav Menon, Patrick D Sutphin, Sonja Bartolome, Sanjeeva P Kalva, Takeshi Ogo

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cardiovascular diagnosis and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Keshav MenonDepartment of Interventional Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Patrick D SutphinDepartment of Interventional Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Sonja BartolomeDepartment of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Sanjeeva P KalvaDepartment of Interventional Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Takeshi OgoDepartment of Advanced Medicine for Pulmonary Hypertension, National Cerebral and Cardiovascular Centre, Osaka, Japan.
Society of Interventional Radiology · USThe University of Texas Southwestern Medical Center · USNational Cerebral and Cardiovascular Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating but potentially reversible complication of chronic pulmonary thromboembolic disease characterized by progressive right heart dysfunction secondary to pulmonary arterial stenosis or occlusion. Balloon pulmonary angioplasty (BPA) has recently emerged as an alternative intervention for non-surgical candidates with CTEPH. Modern reperfusion angioplasty techniques relieve sequela of chronic pulmonary hypertension, ameliorate right ventricular failure, and improve functional status. This article will discuss the diagnosis and treatment of patients with CTEPH and the current state of endovascular management with BPA.

Indexed as

Balloon pulmonary angioplasty (BPA)chronic thromboembolic pulmonary hypertension (CTEPH)

Identifiers

PMID30057875
PMCPMC6039800
OpenAlexW2811081275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.